RI Research Instruments Awarded $7.7M Linear Accelerator Contract from DoE Brookhaven National Laboratory
News Apr 23, 2010
RI Research Instruments GmbH, a majority-owned subsidiary of Bruker Energy & Supercon Technologies (BEST), Inc., has announced the award of a $7.7 million contract from the U.S. Department of Energy's Brookhaven National Laboratory. The contract is for the turn-key supply of a 200 MeV electron injection linear accelerator for BNL's next-generation National Synchrotron Light Source (NSLS-II).
This new contract covers the engineering, manufacturing, integration, delivery, installation and commissioning of the linear accelerator (linac). Delivery is expected in January 2012. A linac represents the first key element of third generation synchrotron light sources. It generates, accelerates and delivers an electron beam of superior quality to be used in a storage ring for generating x-rays, ultraviolet light and infrared light for research in such diverse fields as biology and medicine, chemistry and environmental sciences, physics, and materials science.
According to a BNL publication, their current light source - the National Synchrotron Light Source (NSLS). Meeting the critical scientific challenges of the United States energy future will require advanced new capabilities that a new facility called NSLS-II is expected to provide. Construction of the NSLS-II began in 2009 and initial operation is expected in 2015.
NSLS-II will be a new medium-energy electron storage ring (3 billion electron-volts) designed to deliver intensity and brightness, and produce x-rays more than 10,000 times brighter than the current NSLS.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018